News|Articles|August 2, 2003

Pharmaceutical Technology

  • Pharmaceutical Technology-08-02-2003
  • Volume 27
  • Issue 8

BIO Update

Author(s)Jim Miller

The Biotechnology Industry Organization lends insight into the trends of biopharmaceutical contract manufacturing.


Related to this article

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.